Screening:EUCanScreen (European Union): Difference between revisions
(Created page with "<span style="display:none">forpolicymakers</span> <span style="display:none">europeanunion</span> Go back to European Union page '''Primary purpose:''' To ensure the sustainable implementation of high-quality cancer screening programmes across the European Union, starting with breast, cervical, and colorectal cancer. It also supports the rollout of newly recommended screening for lung, prostate, and gastric cancers to reduce cancer burden and improve equity across M...") |
No edit summary |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
<span style="display:none"> | <span style="display:none">forpatients</span> | ||
<span style="display:none">europeanunion</span> | <span style="display:none">europeanunion</span> | ||
<span style="display:none">isScreening</span> | |||
Go back to [[European Union]] page | Go back to [[European Union]] page | ||
| Line 7: | Line 9: | ||
'''Sponsor, manager or home institution:''' [[dataOwner::EUCanScreen project consortium]]. | '''Sponsor, manager or home institution:''' [[dataOwner::EUCanScreen project consortium]]. | ||
'''Type of information:''' Project information and updates about implementing cancer screening programmes across Europe, including breast, cervical, colorectal, and newer recommended screenings (lung, prostate, and gastric). You can also find work package details, partner organisations, events and training courses, news, publications, country-level campaign activities, and ways to contact or subscribe to updates. | '''Type of information:''' Project information and updates about implementing cancer [[availableVariable::screening]] programmes across Europe, including breast, cervical, colorectal, and newer recommended screenings (lung, prostate, and gastric). You can also find work package details, partner organisations, events and training courses, news, publications, country-level campaign activities, and ways to contact or subscribe to updates. | ||
'''Data level''': [[dataLevel::global level]]. | '''Data level''': [[dataLevel::global level]]. | ||
| Line 14: | Line 16: | ||
'''Access to information:''' [https://eucanscreen.eu/ Click here to access]. | '''Access to information:''' [https://eucanscreen.eu/ Click here to access]. | ||
<span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span> | |||
<span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span> | |||
<span style="display:none">hasCancerType::C50: Breast cancer</span> | |||
<span style="display:none">hasCancerType::C51-C58: Female genitalia cancers</span> | |||
<span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span> | |||
<span style="display:none">Esophageal</span> | |||
<span style="display:none">Gastric</span> | |||
<span style="display:none">Intestinal</span> | |||
<span style="display:none">Bowel</span> | |||
<span style="display:none">Colorectal</span> | |||
<span style="display:none">Appendix</span> | |||
<span style="display:none">Appendiceal</span> | |||
<span style="display:none">Duodenum</span> | |||
<span style="display:none">Jejunum</span> | |||
<span style="display:none">Ileum</span> | |||
<span style="display:none">Anal</span> | |||
<span style="display:none">Perianal</span> | |||
<span style="display:none">Hepatic</span> | |||
<span style="display:none">Biliary</span> | |||
<span style="display:none">Hepatobiliary</span> | |||
<span style="display:none">Pulmonary</span> | |||
<span style="display:none">Thorax</span> | |||
<span style="display:none">Thoracic</span> | |||
<span style="display:none">Chest</span> | |||
<span style="display:none">Mediastinal</span> | |||
<span style="display:none">Pleural</span> | |||
<span style="display:none">Cutaneous</span> | |||
<span style="display:none">Axilla</span> | |||
<span style="display:none">Axillary</span> | |||
<span style="display:none">Mammary</span> | |||
<span style="display:none">Cervical</span> | |||
<span style="display:none">Uterine</span> | |||
<span style="display:none">Endometrial</span> | |||
<span style="display:none">Ovarian</span> | |||
<span style="display:none">Tubal</span> | |||
<span style="display:none">Fallopian</span> | |||
<span style="display:none">Vaginal</span> | |||
<span style="display:none">Vulvar</span> | |||
<span style="display:none">Adnexal</span> | |||
<span style="display:none">Prostatic</span> | |||
<span style="display:none">Testicular</span> | |||
<span style="display:none">Penile</span> | |||
Latest revision as of 14:39, 23 January 2026
Go back to European Union page
Primary purpose: To ensure the sustainable implementation of high-quality cancer screening programmes across the European Union, starting with breast, cervical, and colorectal cancer. It also supports the rollout of newly recommended screening for lung, prostate, and gastric cancers to reduce cancer burden and improve equity across Member States.
Sponsor, manager or home institution: EUCanScreen project consortium.
Type of information: Project information and updates about implementing cancer screening programmes across Europe, including breast, cervical, colorectal, and newer recommended screenings (lung, prostate, and gastric). You can also find work package details, partner organisations, events and training courses, news, publications, country-level campaign activities, and ways to contact or subscribe to updates.
Data level: global level.
Cancer areas of interest: C30-C39: Lung/chest cancers, C15-C26: Digestive system cancers, C50: Breast cancer, C51-C58: Female genitalia cancers and C60-C63: Male genitalia cancer.
Access to information: Click here to access.
